WANDA NUNES: Open Payments
NPI 1477235711 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 31 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $365 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $260 |
| Axsome Therapeutics, Inc. | 7 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| Sage Therapeutics, LLC | 1 | $34 |
| Alkermes, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Corium, LLC | 1 | $14 |
Products named: VRAYLAR, Auvelity, CAPLYTA, REXULTI, ZURZUVAE, ARISTADA, INVEGA SUSTENNA, FANAPT.
Industry payments across MA — which companies pay providers there.
